EGFR and non-small cell lung carcinoma: Previous studies have reported a secondary EGFR mutation at nucleotide 2369 in exon 20, which leads to a substitution of methionine for threonine at position 790 (T790M), in established gefitinib-resistance NSCLC cell lines, and in patients with acquired resistance after gefitinib treatment [14, 15].